Newsroom | 1753 results

LOS ANGELES--(BUSINESS WIRE)--Google's ‘Buyer Beware’ Policy Can Compromise Patient Confidentiality, says AHF...

LONG BEACH, Calif.--(BUSINESS WIRE)--New AHF Wellness Center Provides Crucial HIV and STI Services in Long Beach...

RICHMOND, Va.--(BUSINESS WIRE)--Anthem HealthKeepers Plus, in partnership with the Virginia Harm Reduction Coalition (VHRC), has launched a new initiative to expand access to naloxone through the placement of vending boxes in high-need areas across the Roanoke and Western Piedmont regions. The initiative is part of a broader effort to address the ongoing opioid crisis by increasing access to life-saving resources and supporting community-based harm reduction strategies. Through the partnership,...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the first quarter 2026. “Gilead teams have delivered another strong quarter with 8% year-over-year growth in our base business and 10% growth in HIV, supported by the successful launch of Yeztugo. We have raised our full year revenue guidance as a reflection of our performance," said Daniel O’Day, Gilead’s Chairman and Chief Executive Officer. “Building on the strongest pipel...

LAS VEGAS--(BUSINESS WIRE)--The American Osteopathic Association (AOA) is thrilled to announce registration for the Osteopathic Medical Education Conference, more commonly known as OMED, is now open. This year’s in-person event will take place from Oct. 22-25, 2026, at Caesars Palace in Las Vegas, bringing together thousands of doctors of osteopathic medicine (DOs) and osteopathic medical students for an unparalleled experience of inspiration, learning, networking and professional growth. OMED...

LOS ANGELES--(BUSINESS WIRE)--Gilead's Earnings per Share Expected to Be Up 52% as Florida’s and other States’ AIDS Drug Programs Falters, says AHF...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN) – an investigational, once-daily single-tablet combination regimen for the treatment of HIV in adults who are virologically suppressed. The FDA has granted priority review of the application and assigned a Prescription Drug User Fee Act (PDUFA) action date of Aug...

LOS ANGELES--(BUSINESS WIRE)--AHF's Gilead Shareholder Resolution Seeks Transparency on Patent Exclusivities...

BOSTON--(BUSINESS WIRE)--Outcome Capital, LLC, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that Jaison Ellis has joined the firm as a Managing Director, based in Charlotte, NC. The firm continues to expand its life sciences and healthcare practices through its unique, market-aligned, strategy-driven platform, delivering mergers and acquisitions, partnerships, and strategic advisory services. “I’m delighted to join such a distinguished...

MIAMI--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will cohost a webinar, “Will Equity Prevail? The PABS Annex Negotiations at Their Final Hour,” on Thursday, April 23, 2026 at 10:00 AM EDT, virtually via Zoom. Register here. As WHO Pandemic Agreement negotiations enter a decisive phase ahead of the next Intergovernmental Working Group (IGWG) session, Member States are working to finalize the Pathogen Access and Bene...